In response to the COVID-19 outbreak, the U.S. Biomedical Advanced Research and Development Authority (BARDA) part of Health and Human Services (HHS), seeks information from stakeholders on available medical countermeasures in development. Through the website MedicalCountermeasures.gov the U.S. government has created a portal called CoronaWatch for developers of potential COVID19 vaccines, therapeutics, diagnostics or other technologies to meet with program managers at relevant federal agencies including CDC, FDA and NIH. BARDA also has a open call for COVID19 countermeasures funding through their existing Broad Area Announcement
Technologies sought include:
- Diagnostic assay for human coronavirus using existing FDA-cleared platforms
- Point-of-care diagnostic assay for detection of SARS-CoV-2 virus
- Diagnostic assay for detection of COVID-19 disease (SARS-CoV-2 infection)
- COVID-19 Vaccine
- COVID-19 Therapeutics
- Immunomodulators or therapeutics targeting lung repair
- Pre-exposure and post-exposure prophylaxis
- Respiratory protective devices
- Ventilators
- Advanced Manufacturing Technologies
Through a CoronaWatch meeting stakeholders can engage BARDA and other agencies directly to gain technical feedback and strategic input regarding a proposed technology’s relevance to the government’s needs. The CoronaWatch web portal is serving as the single point of entry for interested entities submitting market research and meeting requests for U.S. government COVID-19 medical countermeasures. At this time, the government is only seeking submissions on COVID-19\.